Evidence map›Paper›PMID 36070155›Full record

ReviewCell and tissue research2023

Mechanisms of prion-induced toxicity.

Robert C C Mercer, David A Harris

Open access · greenAbstract readReview
In one paragraph

Review in Cell and tissue research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. CpG oligodeoxynucleotide reduces PrPMolecules and cells · 2026
    Article
  4. Review
  5. Article
  6. Enhanced lysosomal activity prevents infection with PrPThe Journal of biological chemistry · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robert C C MercerDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, USA.
David A HarrisDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, USA. daharris@bu.edu.ORCID http://orcid.org/0000-0002-6985-5790
Boston University · US

Funding

Mechanisms of Prion Protein ToxicityR01NS065244 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HARRIS, DAVID A · 2010 to 2025
$8.9M
NINDS NIH HHS R01 NS065244
6 · The paper itself

Abstract

Prion diseases are devastating neurodegenerative diseases caused by the structural conversion of the normally benign prion protein (PrP

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesPrion DiseasesPrionsHumansPrion ProteinsPrion ProteinsPrionsNeurodegenerationNeurotoxicityPathogenesisPrion

Identifiers

PMID36070155
PMCPMC12143169
OpenAlexW4294917792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.